Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02482441 |
| Title | A Phase 1a/b Dose Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of OMP-131R10 |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | OncoMed Pharmaceuticals, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| UCSF | San Francisco | California | 95115 | United States | Details | |
| University of Colorado Hospital Anschulz Cancer Pavilion | Aurora | Colorado | 80045 | United States | Details | |
| Yale | New Haven | Connecticut | 06520-8028 | United States | Details | |
| Massachusetts General Hospital, Dana Farber Cancer Institute | Boston | Massachusetts | 02114 | United States | Details | |
| Duke University | Durham | North Carolina | 27710 | United States | Details | |
| The Sarah Cannon Research Institute | Nashville | Tennessee | 37203 | United States | Details | |
| M.D. Anderson Cancer Center | Houston | Texas | 77030 | United States | Details |